Visuals
Sidebar
Telemedicine trends before and during the pandemic
Telehealth has always been in US physicians’ toolkit – but until COVID-19 adoption was relatively slow. In an early-2019 poll ...
Total vaccine doses per 100 people
"There remains a shocking imbalance in the global distribution of vaccines," WHO Director General Tedros Adhanom Ghebreyesus told a news ...
Vaccine hesitancy by zip code
Highlights areas in the United States that would benefit from increased vaccine acceptance. Source: US COVID-19 Symptom Survey
Global vaccination timeline
Timeline predicting when each country will have 60% of their population vaccinated. Source: Statista & Economist Intelligence Unit
Hospitalization rates relative to vaccination rates
A comparison of hospitalization data from the Centers for Disease Control and Prevention and vaccination numbers collected by Our World ...
Beneficiaries receiving medical care for an opioid overdose.
The number of beneficiaries receiving medical care for an opioid overdose peaked in the summer of 2020. Source: Office of ...
State PDMP’s increase rates of opioid overdose
The inception of PDMP's has been followed by increasing rates of opioid overdose and stable rates of drug addiction. Source: ...
IHME model extends to November 01, 2021 – predicts Fall upswing in mortality
Mortality expected to increase 3x from current levels. Increase in excess deaths attributed to spread of Delta variant. Source: ...
Changes in Care Delivery During the COVID-19 Pandemic
Changes in Care Delivery in US Office-Based and Telemedicine Visits During the COVID-19 Pandemic Cecilia Cortez; Omar Mansour, MHS; Dima ...
12 Month-ending Provisional Number of Drug Overdose Deaths by Drug or Drug Class
CDC drug overdose data.
Opioid epidemic in one chart – correlation conflated with causation
There is no cause-and-effect relationship between prescribing and overdose mortality. But millions of patients are being denied safe and effective ...
State by state mental health access ranking
The Access Ranking indicates how much access to mental health care exists within a state. The access measures include access ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more